Pathologic Response to Neoadjuvant Radiotherapy (NRT) as Potential Prognostic Factor in Soft Tissue Sarcomas (SFS)

Pathologic Response to Neoadjuvant Radiotherapy (NRT) as Potential Prognostic Factor in Soft Tissue Sarcomas (SFS)

October 1, 2012  |  Research

Authors: Jason C. Chang, MD1 | David L. Stockman, MD1 | Meena Bedi, MD2 | Dian Wang, MD2 | Eduardo V. Zambrano, MD1
1Department of Pathology and 2Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI

Download the PDF